Appointment marks Neurosoft's expansion beyond stretchable BCI hardware into neural data and AI models for decoding the human cortex, advancing its goal of turning brain interfaces into products people genuinely need.

Neurosoft Bioelectronics welcomes two leading advisors in neuro AI

Geneva, Switzerland, July 31 2025 - Neurosoft Bioelectronics SA, a Swiss company with a US presence in New York, developing scalable implantable brain-computer interfaces, is pleased to announce that Prof. Guillaume Lajoie and Prof. Martin Schrimpf have joined as scientific advisors to support the company’s strategy in neuro artificial intelligence and foundation brain modeling.

Swiss company sets record for most electrodes in a soft and stretchable brain interface tested in a human